X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

VASCULAR PHARMACOLOGY

期刊標題檢索 VASC PHARMACOL 最新評論: Extremely slow, asked multiple times in the middle, but they claimed t... (2022-06-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[VASCULAR PHARMACOLOGY]您好,您是該頁面的第 31444 位訪客。

期刊簡介
期刊名稱VASCULAR PHARMACOLOGY VASCULAR PHARMACOLOGY
LetPub Score
7.4
50 ratings
Rate

Reputation
8.6

Influence
6.2

Speed
9.2

期刊簡稱VASC PHARMACOL
ISSN1537-1891
E-ISSN1879-3649
h-index86
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.600.9690.692
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Physiology
Q255 / 193
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Pharmacology
Q2100 / 313
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q274 / 178

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system.

Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English.

The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.
官方網站http://www.journals.elsevier.com/vascular-pharmacology/
在線稿件提交https://www.editorialmanager.com/VPH
開放訪問No
出版商Elsevier Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年2002
每年文章數68每年文章數趨勢
黃金OA百分比27.45%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ2100/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1537-1891%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Ordinary
在線文章發布時間來自Elsevier的數據: Average 16 Week(s)
參考鏈接
相關期刊 【VASCULAR PHARMACOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY499208
    PHYTOMEDICINE347169
    LIFE SCIENCES295206
    PHARMACOLOGICAL RESEARCH246314
    International Journal of Pharmaceutics243134
    European Journal of Pharmacology205388
    BIOCHEMICAL PHARMACOLOGY203405
    JOURNAL OF NATURAL PRODUCTS197027
    BRITISH JOURNAL OF PHARMACOLOGY165849
    MOLECULAR PHARMACEUTICS163139
  •  

    VASCULAR PHARMACOLOGY VASCULAR PHARMACOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [VASCULAR PHARMACOLOGY] 的評論撰寫評論
作者: Nemo711


領域: 医学
審稿時間: 8.0 month(s)
結果: 拒稿


撰寫評論

2022-06-29 16:30:52 評論於
Extremely slow, asked multiple times in the middle, but they claimed to be unable to find any reviewers. As a result, we found 5-6 reviewers in the end, but only one of them provided substantial feedback. Two were very good, while the other two simply suggested minor revisions. Ultimately, the editor rejected the submission outright. Be cautious when considering submitting to them!
(0) 讚! | Nemo711

作者: 卢子凰


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2020-06-23 21:24:00 評論於
It took two months for the review, and it was not too difficult. The comments given by the reviewers were nice. One week after minor revision, it was accepted. Generally speaking, if the experiments are enough, there will be no big problems.

(1) 讚! | 卢子凰

作者: 道法自然


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2018-11-28 19:17:31 評論於
This journal only publishes a small number of papers each year. Has a high standard for pharmacology. The quality is fairly good. The first round of review takes about 2 months.

(4) 讚! | 道法自然

作者: 水荷酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-28 18:34:15 評論於
Review Speed: 2.0
Experience Sharing: This journal has a low annual publication volume with a high requirement for pharmacology, but the quality is good. The first review process takes around 2 months
(0) 讚! | 水荷酱吖

作者: 墟散高芬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-28 10:10:13 評論於
This magazine has a low annual publication volume, with high requirements for pharmacology and decent quality. The first review cycle is around 2 months
(0) 讚! | 墟散高芬

作者: 北陆梧桐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-08 10:28:39 評論於
Review speed: 12.0 | Submission acceptance rate: 50.0
Experience sharing: This journal is really slow. The first review took two months, and there has been no change in three months for the second review. It's too time-consuming
(0) 讚! | 北陆梧桐

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-01 10:58:57 評論於
We are only 2 points behind, hopefully we can catch up next year
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [VASCULAR PHARMACOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*